Terje R. Pedersen

Terje R. Pedersen works in Preventive Cardiology affiliated with Nuffield Health.

Terje R. Pedersen is the Director of the Center of Preventive Medicine at Oslo University Hospital and University of Oslo. He is a clinical cardiologist and scientist who led the Scandinavian Simvastatin Survival Study (4S) and contributed to multiple ESC/EAS guidelines on the management of dyslipidaemias. He has been involved in major clinical trials such as IDEAL and SEAS, focusing on lipid-lowering therapies.